Medical News

RSS

WHO urged to establish a schedule to phase out the use of dental mercury fillings as soon as possible

Today, at an expert meeting on the future use of dental fillings, a letter signed by over 70 non-governmental organisations from around the world was presented, calling on the World Health Organization (WHO) to establish a schedule to phase out the use of dental mercury fillings as soon as possible.

17 Nov 2009

Employers have serious concerns about healthcare reform, indicates PSG survey

Pharmaceutical Strategies Group (PSG), the nation's largest independent pharmacy benefit consulting firm, released today the results of a national survey of companies focused on their views of proposed healthcare reform legislation.

17 Nov 2009

USPSTF recommendations against regular mammography screening can result in unnecessary breast cancer deaths

If cost-cutting U.S. Preventive Services Task Force (USPSTF) mammography recommendations are adopted as policy, two decades of decline in breast cancer mortality could be reversed and countless American women may die needlessly from breast cancer each year.

17 Nov 2009

Aterovax presents results of its sPLA2 activity test in the PEACE trial

Aterovax SA, a company developing innovative products for atherosclerosis, today announced data demonstrating that its blood test for secretory phospholipase A2 (sPLA2) activity significantly improves cardiovascular risk prediction in patients with stable coronary artery disease (CAD) over a 5 year period, independent of established risk markers, including C-reactive protein.

17 Nov 2009

Researchers discover a way to boost levels of palmitoylethanolamide

UC Irvine pharmacology researchers have discovered a way to boost levels of a natural body fat that helps decrease inflammation, pointing to possible new treatments for allergies, illnesses and injuries related to the immune system.

17 Nov 2009

UMG to acquire the Del Medical Imaging US business from Del Global Technologies

UMG Inc., a privately held company headquartered in Harrison, New York, has entered into an Agreement in principle to acquire the Del Medical Imaging US business from Del Global Technologies Corp. Both parties anticipate the transaction will be completed prior to December 1, 2009.

17 Nov 2009

UC San Diego Medical Center to implement Allocade's On-Cue System

As part of ongoing efforts to improve patient services, the Department of Radiology at UC San Diego is participating in the Enterprise Patient Flow (EPF) Study. UC San Diego Medical Center will implement the On-Cue™ System -- developed by Allocade, Inc., a developer of innovative healthcare software solutions -- to study process improvement, resource utilization, communication and patient experience.

17 Nov 2009

New, reversible antiplatelet drug not superior than irreversible one in patients undergoing PCI

A new, reversible antiplatelet drug did not demonstrate superiority over a current irreversible one in reducing the composite of death, heart attack or ischemia-related revascularization in the 48 hours after angioplasty, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009.

17 Nov 2009

Molecular makeup of current H1N1 flu strain strikingly different from previous H1N1 strains

As the number of deaths related to the pandemic H1N1 virus, commonly known as "swine flu," continues to rise, researchers have been scrambling to decipher its inner workings and explain why the incidence is lower than expected in older adults.

17 Nov 2009

Shire publishes new study results on INTUNIV Extended-Release Tablets

Shire plc, the global specialty biopharmaceutical company, announced new study results on INTUNIV- (guanfacine) Extended-Release Tablets published in the October Journal of Child and Adolescent Psychopharmacology. In this open-label safety study, there was no evidence of unique adverse effects with the combination of INTUNIV and amphetamine or methylphenidate relative to what was observed with either medication alone.

17 Nov 2009

PsoriasisDX to present seminar on Genetic Screening for Psoriatic Arthritis

A seminar on Genetic Screening for Psoriatic Arthritis will be presented on Tuesday, December 8 from 12-1 PM Pacific Standard Time, hosted by pharmacogenomics research and development innovators PsoriasisDX, pioneers of the world’s first genetic test for psoriatic arthritis (PsA). The seminar will feature leading experts Dr. John Koo and Dr. Wilson Liao.

17 Nov 2009

Global financial crisis has major long-term health implications for Australia

One in four Australian adults has taken an action that puts their health at risk as a result of the global financial crisis (GFC), according to a new MBF Healthwatch poll.

17 Nov 2009

Upsher-Smith Laboratories publishes results of SLIM Study

Results of the SLIM Study ("Slo-Niacin® and Atorvastatin Treatment of Lipoproteins and Inflammatory Markers in Combined Hyperlipidemia") were recently published in the Journal of Clinical Lipidology.

17 Nov 2009

DNA banking: A step toward preserving history and improving the health of future generations

This Thanksgiving Day marks the sixth annual National Family History Day, a U.S. Department of Health and Human Services initiative to encourage families to discuss their health history. Holiday gatherings are excellent opportunities for discussing and documenting family disease backgrounds which can save the lives of loved ones through early detection and preventive measures.

17 Nov 2009

Survey reveals discrepancy between perception and reality in CPR knowledge and skill level

The CPR Improvement Working Group, formed to help improve cardiopulmonary resuscitation (CPR) skill performance, today announced the results of the first-ever, multi-national attitudinal survey concerning the performance of CPR by healthcare professionals, including doctors, nurses and paramedics. Survey results will be presented concurrently with the American Heart Association's annual meeting in Orlando, Florida at a panel discussion of leading resuscitation experts on Monday, November 16.

17 Nov 2009

LEAD Therapeutics discovers orally available PARP inhibitor

LEAD Therapeutics, a privately held drug discovery company, today announced the discovery of a novel, orally available, PARP inhibitor with potent anti-tumor activity both as single-agent treatment and in combination with chemotherapy drugs.

17 Nov 2009

Improved productivity and lowered absenteeism are top priorities for business leaders

Improving productivity by keeping employees healthy and working is emerging as the top business objective for employer-sponsored wellness programs around the world. The two exceptions are the United States, where reducing health care cost increases overwhelmingly continues to be the top goal, and Asia, where the most important objective is improving workforce morale.

17 Nov 2009

deCODE genetics files voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code

deCODE genetics, Inc. (Nasdaq: DCGN) today announced that it has filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code with the United States Bankruptcy Court for the District of Delaware to facilitate the sale of substantially all of its assets. deCODE is continuing to operate its business and manage its properties as a debtor-in-possession pursuant to Sections 1107 and 1108 of the Bankruptcy Code.

17 Nov 2009

CD4 Initiative selects Zyomyx's CD4 POC technology as best for measuring CD4 T-cell count in HIV/AIDS patients

Zyomyx, Inc., a leader in chip-based bioanalysis technologies, today announced that its readerless CD4 point-of-care (POC) technology was selected by Imperial College London's CD4 Initiative as the best-performing POC test method for measuring CD4 T-cell count in HIV/AIDS patients. Zyomyx's CD4 assay is now the only remaining POC product being supported by the CD4 Initiative.

17 Nov 2009

GE Healthcare announces results from ongoing evaluation of Gemstone Spectral Imaging

GE Healthcare today announced results from its ongoing customer evaluation of Gemstone Spectral Imaging, a technology aiming to enhance CT’s diagnostic capability. Gemstone Spectral Imaging is an available option for Discovery CT750HD systems and is being delivered to customers worldwide.

17 Nov 2009

Medical News

WHO urged to establish a schedule to phase out the use of dental mercury fillings as soon as possible

Employers have serious concerns about healthcare reform, indicates PSG survey

USPSTF recommendations against regular mammography screening can result in unnecessary breast cancer deaths

Aterovax presents results of its sPLA2 activity test in the PEACE trial

Researchers discover a way to boost levels of palmitoylethanolamide

UMG to acquire the Del Medical Imaging US business from Del Global Technologies

UC San Diego Medical Center to implement Allocade's On-Cue System

New, reversible antiplatelet drug not superior than irreversible one in patients undergoing PCI

Molecular makeup of current H1N1 flu strain strikingly different from previous H1N1 strains

Shire publishes new study results on INTUNIV Extended-Release Tablets

PsoriasisDX to present seminar on Genetic Screening for Psoriatic Arthritis

Global financial crisis has major long-term health implications for Australia

Upsher-Smith Laboratories publishes results of SLIM Study

DNA banking: A step toward preserving history and improving the health of future generations

Survey reveals discrepancy between perception and reality in CPR knowledge and skill level

LEAD Therapeutics discovers orally available PARP inhibitor

Improved productivity and lowered absenteeism are top priorities for business leaders

deCODE genetics files voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code

CD4 Initiative selects Zyomyx's CD4 POC technology as best for measuring CD4 T-cell count in HIV/AIDS patients

GE Healthcare announces results from ongoing evaluation of Gemstone Spectral Imaging

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Latest News